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Abstract
Objective: To analyse the variation in the rate of adverse events (AEs) between acute hospitals
and explore the extent to which some patients and hospital characteristics influence the differ-
ences in the rates of AEs.
Design: Retrospective cohort study. Chi-square test for independence and binary logistic regres-
sion models were used to identify the potential association of some patients and hospital charac-
teristics with AEs.
Setting: Nine acute Portuguese public hospital centres.
Participants: A random sample of 4250 charts, representative of around 180 000 hospital admis-
sions in 2013, was analysed.
Intervention: To measure adverse events based on chart review.
Main Outcome Measure: Rate of AEs.
Results: Main results: (i) AE incidence was 12.5%; (ii) 66.4% of all AEs were related to Hospital-
Acquired Infection and surgical procedures; (iii) patient characteristics such as sex (female 11%;
male 14.4%), age (≥65 y 16.4%; <65 y 8.5%), admission coded as elective vs. urgent (8.6% vs.
14.6%) and medical vs. surgical Diagnosis Related Group code (13.4% vs. 11.7%), all with p <
0.001, were associated with a greater occurrence of AEs. (iv) hospital characteristics such as use
of reporting system (13.2% vs. 7.1%), being accredited (13.7% vs. non-accredited 11.2%), univer-
sity status (15.9% vs. non-university 10.9%) and hospital size (small 12.9%; medium 9.3%; large
14.3%), all with p < 0.001, seem to be associated with a higher rate of AEs.
Conclusions: We identified some patient and hospital characteristics that might influence the rate
of AEs. Based on these results, more adequate solutions to improve patient safety can be defined.
Key words: patient safety, adverse events < patient safety, hospital care < setting of care, public health < health-care system,
health-care associated infections < complications
© The Author(s) 2018. Published by Oxford University Press in association with the International Society for Quality in Health Care. 132
This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-
nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way,
and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
Downloaded from https://academic.oup.com/intqhc/article-abstract/30/2/132/4788583
by Inaie Wendel user
on 09 March 2018
Introduction
The identification and measurement of adverse events (AEs) is cru-
cial for enhancing patient safety, hierarchizing priorities for inter-
vention, defining important research areas, and evaluating the
impact of the developed solutions in improving safety and quality of
care.
In the last 15 years, several studies have been developed with the
aim of estimating the rate of adverse events and characterizing their
nature, impact and preventability in several countries, including
Portugal [1–4]. In response to the results of those studies, patient
safety strategies, programmes and interventions have been imple-
mented with a view to improving patients’ outcomes by reducing the
harm associated with the health-care delivered. However, globally,
the problem of patient harm continues to exist and turning the prob-
lem around has proven difficult.
More recently, some comparative longitudinal studies within the
same group of hospitals have been published [5–9], comparing AEs
between countries [10], evaluating the costs associated with AEs
[11, 12]; analysing the reliability of the research methods based on
medical record reviews [13–15], and making comparisons of AEs
between hospitals and departments [9, 16].
A small number of those studies have included some analyses
regarding patient complexity/case mix (e.g. the Charlson Comorbidity
Index) and some characteristics of hospitals (e.g. university vs. non-
university, accredited vs. non-accredited hospitals) [17, 18]. However,
there is limited information regarding the extent to which specific
patient and hospital characteristics can influence the differences in the
rates of adverse events. This knowledge is of most value in helping lea-
ders and health-care professionals define and implement specific strat-
egies and approaches, according to patient risks, and in contributing
to the improvement of hospital conditions towards an environment
of safer care.
The aims of this study were to analyse the variation in the rates
of adverse events between acute public hospitals in Portugal and to
explore the extent to which some patient and hospital characteristics
are associated with rates of adverse events. In this study, we also
estimated costs related to the additional length of stay due to the
occurrence of AEs.
Methods
This work was based on a retrospective cohort study and was car-
ried out at nine acute public hospital centres in Portugal. Although
the participating hospitals were selected by convenience, they reflect
the major characteristics of other public hospitals in Portugal
regarding dimension (number of beds), 24-h emergency department,
intensive care unit, medical and surgical departments, and case mix
index of patients treated. No specialist hospitals (e.g. Paediatric,
Oncology and Obstetric) were included in the study.
The sampling frame included all admissions of patients over 18
years old who had a minimum stay in hospital of 24 h. Hospital
admissions with a primary diagnosis related to psychiatry were
excluded. The samples were stratified per hospital cluster, based on
the total number of inpatient episodes per year. Taking into consid-
eration hospital size (inpatient episodes per year), and through the
use of percentiles (cut-offs: P33 and P66), three groups/clusters of
hospitals were defined: small hospitals, those that have up to 10 000
inpatient episodes per year; medium-size hospitals, from 10 001 to
18 000; and large hospitals, with over 18 001 inpatient episodes per
year. The global sample size was 4250 medical charts, assuming a
margin of error of 1%, a 95% confidence level and an expected AE
rate of 11.1% [4, 19], representative of around 180 000 hospital
admissions (which corresponds to around 24% of all adult hospital
admissions in Portuguese public hospitals for the period under ana-
lysis—01 January to 31 December 2013). After that, taking into
consideration the proportions of admissions in each type of hospital
(small, medium and large), the final sample sizes were: 2 small hos-
pital centres sampling 290 medical charts each; 3 medium-size hos-
pital centres sampling 470 medical charts each; and 4 large hospital
centres sampling 565 medical charts each. Random numbers per
hospital were then generated [19] and the corresponding medical
charts were identified and included in the study.
The methods and main definitions used in this study were based
on the protocol used in the Harvard Medical Practice Study [20]
with the subsequent modifications introduced in a Canadian study
[1]; this latter protocol was used in a pilot Portuguese study [4]. A
two-stage structured retrospective medical records review was done
based on the use of 18 screening criteria. In the first stage, a group
of 38 nurses (composed of two to four from each hospital and with
a minimum of 5 years experience in clinical audits) assessed the
medical records, in order to find the presence of at least one of the
18 screening criteria for the presence of a potential adverse event. In
Stage 2, a group of 26 physicians (with a minimum of 5 years
experience in clinical codes and in clinical audits) reviewed each
positive record in order to confirm the presence of an adverse event,
estimate its impact and determine its preventability according to a
previously established definition. The degree of agreement between
the reviewers in each stage was calculated by using the kappa coeffi-
cient. Agreement rate was calculated by dividing the total number of
concordant answers by the number of total answers.
International Classification of Diseases (ICD) codes in main and
secondary diagnoses and procedures were collected from all
patients. Based on the main and secondary diagnoses, we estimated
the Charlson Comorbidity Index (CCI) for each patient sample.
Hospital characteristics, such as accreditation status, the existence
of an AE report system and an electronic drug-prescribing system,
type of hospital—university vs. non-university—and the size of hos-
pitals (based on the number of admissions per year) were also
considered.
As a first approach, global and per hospital rates were computed
while considering the incidence of adverse events, preventability
rates, the proportion of AEs without harm or with minimum injury
and the proportion of deaths. Confidence intervals were computed
using a conventional formula for relatively large samples (n > 30).
Moreover, the proportion of AEs that caused extra bed days and the
mean of extra bed days were estimated together with the consequen-
tial additional costs. The costs related to the additional length of
stay were estimated based on official accounting data from the NHS
hospitals, providing information on daily costs.
Chi-square independency tests and binary logistic regression
models (method: enter) were used to characterize potential associa-
tions of AEs with patient characteristics (e.g. age, sex, medical vs.
surgical DRG code, urgent vs. elective admission) and hospital char-
acteristics (e.g. existence of an AE report system, accreditation sta-
tus, electronic drug-prescribing system, university vs. non-university,
and size). The t-test was used to compare Charlson Comorbidity
Index means, considering both AE and no AE event groups. SPSS
(version 22) was used for data processing and for statistical analysis.
All tests were performed with a level of statistical significance of
0.05. The study was approved by the Ethics Committee of the
hospitals.
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Results
A total of 4225 admissions from nine hospital centres were ana-
lysed. One or more of the criteria for an adverse event were identi-
fied in 1029 reviewed medical records (24.3%). Of these 1029
records that passed to the second screening, a total of 529 (51.4%)
were confirmed as an AE, representing an overall incidence rate of
12.5% (529/4225) with a 95% CI (11.5%; 13.6%). Of the AEs
identified, 39.7% (210/529) were hospital-acquired infection,
26.7% (141/529) were related to surgical procedures, 9.8% (52/
529) were due to drug errors, and 7% (41/529) were falls. The
remaining 17% were related to pressure ulcers, accidental burns and
diagnostic errors.
Most of the AEs (66.1%—350/529) occurred in patients aged
65 or over. Comparing groups with and without AEs, age presents a
mean difference of 8.2 years (mean ± standard deviation: 68.7 ±
17.2 vs. 60.5 ± 20.4 years old, respectively).
Most of the AEs (67.4%—356/529; CI 63.4–71.4) resulted in no
or minimal physical impairment or disability, and were satisfactorily
resolved during the admission, or within one month of discharge.
We estimated that 3.0% (16/529; CI 1.5–4.5%) of the AEs resulted
in permanent disability according to the pre-established definition
[1, 4] and 12.5% (66/529; CI 9.7–15.3%) resulted in death. With
regard to preventability, 39.9% (211/529; CI 35.7–44.1%) were
classified as preventable.
The reliability of the assessment of screening criteria performed
by nurses was considered moderate (k = 0.58; CI 0.41; 0.74 and
p = 0.000; 82% agreement). In the second stage, the inter-rater
agreement for the determination of AEs by doctors was considered
good (k = 0.77; CI 0.53; 1.01, p = 0.000, 89% agreement).
We also found that 60.8% (322/529; CI 56.6–65.0%) of the
patients who experienced AEs incurred extra bed days in hospital
(a total of 3091 extra days, at an average of 9.6 days per patient,
ranging from 1 to 73 days), with an additional estimated cost of €1.9
million for the NHS. Of these 1.9 million, around 1.1 million were
associated with AEs considered avoidable.
Table 1 shows some descriptive statistics of the total rate of AEs,
distributions per sex, preventability, death and prolonged length of
stay (LOS), computed based on hospital-level aggregated measures.
Bivariate analysis
Some patient characteristics were associated with large rates of AEs,
such as being male (14.4%), aged over 65 years old (16.4%), admis-
sions coded as urgent (14.6%) and medical DRG type (13.4%). The
Charlson Comorbidity Index (with a mean of 3.05 in the AE group
vs. 2.27 in the no AE group, p < 0.001) also showed statistical per-
tinence (Table 2).
As regards hospital characteristics, the following categories pre-
sented higher rates of AEs, with statistical relevance (p < 0.001): the
use of a reporting system (13.2%), accredited status (13.7%), uni-
versity type (15.9%) and the size of the hospitals (small 12.9%,
medium 9.3% and large 14.3%) (Table 3).
Table 4 shows the strength of the associations of those patient
and hospital characteristics with the occurrence of AEs.
In terms of patient characteristics, male gender (OR = 1.36; p =
0.001), age >65 years old (OR = 2.10; p < 0.001), urgent cases
(OR = 1.83; p < 0.001) and CCI score (OR = 1.21; p < 0.001) all
presented higher probabilities of suffering an AE. With regard to
hospital characteristics, the existence of a reporting system (OR
2.01; p < 0.001), being accredited (OR = 1.54; p = 0.014), medium
size (OR = 0.69; p = 0.012) and teaching status (university hospital,
OR = 1.54; p < 0.001) all present higher probabilities of AEs.
Discussion
In this study, reviews of medical records were performed in order to
assess the variation in the incidence, nature, and clinical and eco-
nomic impact of adverse events between hospitals. The study also
aimed to provide some insights into the relationship between the
rate of those events and some of the patient and hospital
characteristics.
The total rate of AEs was 12.5%, which is in line with previous
studies [3, 4, 16]. The majority of AEs (66.1%) occurred in patients
aged 65 or older. This is an important finding because it allows us
to identify a particularly vulnerable population that is more likely to
have several health conditions, receive multiple treatments, be often
prescribed a wide range of medication and stay longer periods in
hospital [17, 18, 21], i.e. a population at a higher risk of suffering
an AE. Moreover, this demographic shift towards an older popula-
tion associated with the complexity of care delivery creates a new
potential for error and harm and, for that reason, a challenge for
patient safety [22].
Of all AEs, 39.7% were related to hospital-acquired infections,
followed by 26.7% associated with surgical procedures and 9.8%
related to medication. Similarly to other studies, these three types of
occurrences represent 76.2% of all AEs—over three-quarters of the
total number of identified AEs [3, 5, 10, 14]. The identification and
prioritization of areas to be enhanced, based on their casuistic and
clinical, economic and social impact, is a very rational strategy for
quality and safety improvement. Therefore, the adoption of good
practices, some of them very simple, such as the use of bundles for
insertion and maintenance of central venous and urinary catheters,
the strict compliance with the five moments of hand hygiene, the use
of surgical checklists and medication reconciliation, will be trans-
lated into huge safety gains [23–26].
The majority of AEs (67.4%) did not result in any significant
physical impairment or disability, and were resolved during the in-
hospital period. However, a small but significant proportion of
patients died or experienced a permanent disability as a result of
Table 1 Descriptive statistics of AEs rates, sex, preventability, death and prolonged LOS, using hospital-level information
Total AE (%) AEs in female group (%) AES in male group (%) Preventability (%) Death (%) Prolonged LOS (%)
Min 6.8 5.4 7.7 5.9 4.5 48.1
Max 20.0 16.7 22.9 68.4 23.5 82.4
Mean 11.3 10.3 12.7 38.8 13.1 60.3
SD 4.8 3.9 6.0 20.1 7.2 12.3
Median 10.0 9.3 10.8 41.5 11.9 55.6
SD, standard deviation.
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their AE (12.5% and 3.0%, respectively). This is a similar percent-
age to that reported in other studies [1, 2].
Our findings show that the majority of patients (60.8%) who
experienced AEs prolonged their length of stay in hospital by on
average 9.6 days, with an estimation of additional costs of €1.9 mil-
lion, of which 1.1 million were associated with preventable AEs.
This is an underestimated value as it does not take into account
costs related to additional ambulatory treatment or other hospitali-
zations related to the same AE. Moreover, it does not account either
for other indirect and social costs (e.g. premature death, absence
from work). As other studies have highlighted, there is an urgent
need for more detailed and rigorous analyses in order to achieve
robust results regarding the economic impact of AEs [12, 27].
The inter-rater agreement, for identifying a positive criterion and
for the confirmation of an AE were considered moderate and good,
respectively. These results are in line with those found in other stud-
ies [1, 13].
This study gives some insights into patient and hospital charac-
teristics that can influence the rate of AEs. In the bivariate analysis,
all the five patient covariates studied present differences that are
statistically significant. The occurrence of AEs was higher in males,
patients aged 65 or older, urgent admissions, surgical cases and
patients with greater CCI scores. Elderly patients, due to natural
physiological and physical changes associated with aging, present
frailer and weaker health conditions, have a higher number of risk
factors and co-morbidities, which results in the need to receive sev-
eral treatments (in some situations of high complexity), take mul-
tiple medication and stay longer periods in hospital to recover from
their illness [14, 21, 28]. Therefore, the risk of slips, falls, acquiring
an infection, being a victim of a medication error or having an
adverse drug reaction is higher.
Patients who were admitted as urgent admissions, those with
higher CCI scores and those that were submitted to surgeries pre-
sent, in general, more severe and acute clinical conditions that
require a more complex and riskier health-care delivery [17, 28].
With regard to hospital characteristics, those that have a report-
ing system, are accredited and have the status of university hospitals
present a higher rate of AEs with differences that are statistically sig-
nificant. One plausible explanation is the fact that those hospitals
have a stronger culture of risk awareness and also a systematic prac-
tice of data collection and analysis [29, 30]. These results are in line
with other studies that state that the estimated rates of AEs are only
Table 2 Association between AE and patient characteristics
Patient characteristics Total (n) AE, n (%) Without AE, n (%) p-value
Sex
Male 1896 273 (14.4%) 1623 (85.6) 0.001
Female 2328 256 (11%) 2072 (89%)
Age
<65 years old 2084 178 (8.5%) 1906 (91.5%) <0.001
≥65 years old 2141 351 (16.4%) 1790 (83.6%)
Elective vs. urgent
Elective 1470 126 (8.6%) 1344 (91.4%) <0.001
Urgent 2755 403 (14.6%) 2352 (85.4%)
Medical vs. surgical
Medical 2075 278 (13.4%) 1797 (86.6%) <0.001
Surgical 1866 218 (11.7%) 1648 (88.3%)





aIndependent-samples t-test (comparing means).
Table 3 Association between AE and hospital characteristics
Hospital characteristics Total (n) AE, n (%) without AE, n (%) p-value
Reporting system
Yes 3731 494 (13.2%) 3237 (86.8%) <0.001
No 494 35 (7.1%) 459 (92.9%)
Accreditation status
Yes 2297 314 (13.7%) 1983 (86.3%) <0.001
No 1928 215 (11.2%) 1713 (88.9%)
Type of hospital
University 1356 216 (15.9%) 1143 (84.1%) <0.001
Non-university 2866 313 (10.9%) 2553 (89.1%)
Hospital dimension
Small (<10 000 admission/year) 721 93 (12.9%) 628 (87.1%) <0.001
Medium (from 10 001 to 18 000 admissions/year) 1321 123 (9.3%) 1198 (90.7%)
Large (≥18 001 admissions/year) 2183 313 (14.3%) 1870 (85.7%)
Electronic prescribing drug
Yes 2239 295 (13.2%) 1943 (86.8%) 0.183
No 1987 234 (11.8%) 1753 (88.2%)
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the ‘tip of the iceberg’, as the magnitude of the problem is much lar-
ger [14, 31]. Nevertheless, better quality of data and better use of
the same will contribute to the designing of safer systems, and to
reducing the frequency of AEs.
Some studies have also found that university hospitals have high-
er rates of AEs. The fact that university hospitals have more
advanced technology, enabling them to provide specialized services,
and treat rare diseases and severely ill patients, means that they
receive the most critical cases and, therefore, provide more complex
and riskier care [29, 32]. Moreover, due to the teaching status (med-
ical education and training of other health-care professionals) of
these hospitals, the large number of students that come into contact
with patients, carrying with them different levels of knowledge and
safety culture awareness, may contribute to the large variation in
processes and impacts on health outcomes.
In order to have more robust information to help policymakers,
health managers, health-care professionals, patients and their fam-
ilies to develop and adopt measures that will improve safety and
quality of care, additional research is needed to explore organiza-
tion, patient and care characteristics that may contribute to higher
rates of AEs.
This study presents some limitations, starting with those under-
lying retrospective studies, such as information bias and hindsight
bias. In our analyses, we didn’t account for possible bias related to
different levels of hospital awareness of the occurrence of AE that
can influence the results obtained, namely the use of an electronic
drug-prescribing system, accreditation status and a reporting system.
At the time the study was being developed, the introduction of elec-
tronic drug-prescribing systems was just starting and the reporting
system for AEs was in an early stage in some hospitals.
It would be good to use, in future studies, larger samples and
complementary methods, namely qualitative approaches, in order to
obtain more comprehensive and robust results. Despite the weak-
nesses and limitations present in this type of study, retrospective
analyses of medical charts still represent the most used and the gold
standard method for assessing the incidence and monitoring fre-
quency of AEs [1, 3, 5, 8, 10, 13, 15].
We assume that the effects of the patient and hospital variables
studied partly reflect the most relevant collected characteristics that
could influence the rate of AEs. Future research is, therefore, needed
in order to provide a stronger body of knowledge that will allow
optimal adjustment for the patient case mix and hospital specificities
to be obtained. Only with such data will it be possible to tailor
safety procedures/solutions that will result in the improvement of
care for different groups of patients according to their risk of suffer-
ing an AE.
Conclusion
Despite some limitations, this study adds some interesting insights
related to patient and hospital characteristics that can influence the
frequency of AEs in Portuguese public acute care hospitals and also
the burden of injury resulting from the same.
These results could be seen as a small but important step toward
enhancing safety in the care provided in Portuguese public acute
hospitals. Knowledge of a set of characteristics related to the popu-
lation treated and to the structure of such hospitals, where care is
delivered, is crucial in helping to develop and implement strategies
and solutions aimed at reducing AE rates and, therefore, in moving
towards a culture and practice of quality and safety of care.
Hospital adverse events continue to be an important public
health issue. They constitute a burden in terms of clinical, economic
and social impact and, for that reason, they are a challenge for the
health system not only in Portugal but also worldwide.
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